CURIA INDIA PRIVATE LIMITED

Overview

CURIA INDIA PRIVATE LIMITED is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering FUROSEMIDE USP.

API / Drug Master Files

CURIA INDIA PRIVATE LIMITED holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • FUROSEMIDE USPActive2016-02-29

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CURIA INDIA PRIVATE LIMITED in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.